News
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...
COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major Trump administration policy shift.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...
1h
Agence France-Presse on MSNUS to limit Covid boosters to over-65s or those at high riskThe United States will restrict routine Covid-19 boosters to people over 65 or those at higher risk of serious illness, while ...
Explore more
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results